Literature DB >> 8709818

Apolipoprotein-E genotyping in diagnosis of Alzheimer's disease.

B A Kakulas, S D Wilton, V A Fabian, T M Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8709818     DOI： 10.1016/s0140-6736(05)64588-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Clinical overdiagnosis of vascular dementia versus necropsy confirmed series.

Authors:  A D Roses; A M Saunders
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

Review 2.  Hippocampal atrophy and apolipoprotein E genotype are independently associated with Alzheimer's disease.

Authors:  C R Jack; R C Petersen; Y C Xu; P C O'Brien; S C Waring; E G Tangalos; G E Smith; R J Ivnik; S N Thibodeau; E Kokmen
Journal:  Ann Neurol       Date:  1998-03       Impact factor: 10.422

3.  Cerebrospinal fluid tau protein as a biochemical marker for Alzheimer's disease: a community based follow up study.

Authors:  N Andreasen; E Vanmechelen; A Van de Voorde; P Davidsson; C Hesse; S Tarvonen; I Räihä; L Sourander; B Winblad; K Blennow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-03       Impact factor: 10.154

Review 4.  Use of genetic variation as biomarkers for Alzheimer's disease.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

Review 5.  Use of genetic variation as biomarkers for mild cognitive impairment and progression of mild cognitive impairment to dementia.

Authors:  Christiane Reitz; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Panel of Genetic Variations as a Potential Non-invasive Biomarker for Early Diagnosis of Alzheimer's Disease.

Authors:  Suk Ling Ma; Linda Chiu Wa Lam
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-08-31       Impact factor: 2.582
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.